

<HTML>
<HEAD>

<link rel="stylesheet" href="/v3.css" type="text/css">










<TITLE>NEJM -- Case 23-2003 - A 79-Year-Old Woman with Gastric Lymphoma and Erosive Mucosal and Cutaneous Lesions</TITLE>
<meta name="description" content="Case Records of the Massachusetts General Hospital from The New England Journal of Medicine -- Case 23-2003 - A 79-Year-Old Woman with Gastric Lymphoma and Erosive Mucosal and Cutaneous Lesions">

<meta name="robots" content="nofollow">




<script type="text/javascript" src="/misc/folders.js"></script>
</HEAD>


  

























	




















<!-- start PPT check-->


<!-- end PPT check-->









 
 
  







<body bgcolor="#FFFFFF" link="#FF3300" vlink="#666699" text="#000000" alink="#FF3300">

<!-- BEGIN: Use this section to set page specific variables for the NetTracker Page Tag -->
<script language="JavaScript">
// var NTPT_PGEXTRA = '';
// var NTPT_PGREFTOP = false;
// var NTPT_NOINITIALTAG = false;
</script>
<!-- END: Use this section to set page specific variables for the NetTracker Page Tag -->
<!-- BEGIN: NetTracker Page Tag -->
<!-- Copyright 2004 Sane Solutions, LLC. All rights reserved. -->
<script language="JavaScript" src="/ntpagetag.js"></script>
<noscript>
<img src="/icons/ntpagetag.gif?js=0" height="1" width="1" border="0" hspace="0" vspace="0" alt="">
</noscript>
<!-- END: NetTracker Page Tag -->







<!-- No CheckM8 category -->




<A NAME="top"><!-- null --></A>

	<table width="100%" border="0" cellspacing="0" cellpadding="0" align="center">
	
	
	<tr align="center"> 
	<td bgcolor="#FF3300"><img src="/icons/spacer.gif" width="1" height="3" alt=""></td>
	</tr>
	
	<tr align="center"> 
	<td><a href="/"><img src="/icons/banner/v2_title_large.gif" border="0" alt="The New England Journal of Medicine" width="482" height="95"></a></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><img src="/icons/spacer.gif" width="100%" height="5" alt=""></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><font face="arial, helvetica, sans-serif">
<a href="/" class="navBarLinks">HOME</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/search.dtl" class="navBarLinks">SEARCH</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/current.shtml" class="navBarLinks">CURRENT ISSUE</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/contents-by-date.0.shtml" class="navBarLinks">PAST ISSUES</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/collections/" class="navBarLinks">COLLECTIONS</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/help/" class="navBarLinks">HELP</a>
</font></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><img src="/icons/spacer.gif" width="100%" height="5" alt=""></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#FF3300"><img src="/icons/spacer.gif" width="1" height="3" alt=""></td>
	</tr>
	
	<tr> 
	<td><img src="/icons/spacer.gif" width="100%" height="1" alt=""></td>
	</tr>
	
	<tr> 
	<td><font face="arial, helvetica, sans-serif" size="-2"><!-- subline logic: standard default -->







	
	

	





	
	
	
	 

	


	
	




				<FONT SIZE=-2>




				<NOBR><STRONG>Institution: BRANDEIS UNIV</STRONG></NOBR>

				
	   				
					
				
				| <NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F349%2F4%2F382">Sign In as Individual</A></NOBR>
				|
				<NOBR><A TARGET="_top" HREF="mailto:keen@brandeis.edu">Contact Subscription Administrator at Your Institution</A></NOBR>
				
				 | <NOBR><STRONG><A TARGET="_top" HREF="http://www.nejm.org/Institute/faq.asp">FAQ</A></STRONG></NOBR>

				</FONT>
			

 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	


</font></td>
	</tr>
	
		
		<tr>
		<td>&nbsp;</td>
		</tr>
	
	
	</table>
	
	
<!-- include file -->
<!-- (do not remove) -->




         
                
        






<CENTER>
<table width="640" border="0" cellspacing="0" cellpadding="0">
	<TR VALIGN="TOP"> 
		<TD> 
			
								
				
				<DIV ALIGN="CENTER">
	<IMG VSPACE="7" SRC="/icons/content/v2_case_rec_head.gif" ALT="Case Records of the Massachusetts General Hospital">
	  
	  
	    
	    
	  
	

	
	
	
	
	
	
	
	
	
	
	  
	    <BR><IMG SRC="/icons/content/series/case_weekly_clinio_subonly.gif" ALT="Weekly Clinicopathological Exercises">
	  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	

				
          		<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="640">
				<TR>
					<TD VALIGN="TOP" NOWRAP><A HREF="/cgi/content/short/349/4/366?query=prevarrow"><IMG ALT="Previous" WIDTH="9" HEIGHT="8" HSPACE="4" BORDER="0" SRC="/icons/v2_toc_arrowprev.gif"><FONT SIZE="-1" FACE="arial,helvetica">Previous</FONT></A></TD>
          			<TD ALIGN="CENTER" VALIGN="TOP"><TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
						<TH ALIGN="RIGHT" VALIGN="TOP" NOWRAP>Volume 349:382-391</TH>
						<TD NOWRAP><IMG ALT="" WIDTH="30" HEIGHT="30" SRC="/icons/spacer.gif"></TD>
						<TH VALIGN="TOP" NOWRAP><A HREF="/content/vol349/issue4/index.shtml"><FONT COLOR="#000000">July 24, 2003</FONT></A></TH>
						<TD NOWRAP><IMG ALT="" WIDTH="30" HEIGHT="30" SRC="/icons/spacer.gif"></TD>
						<TH ALIGN="LEFT" VALIGN="TOP" NOWRAP>Number 4</TH>
					</TR></TABLE></TD>
					<TD VALIGN="TOP" ALIGN="RIGHT" NOWRAP><A HREF="/cgi/content/short/349/4/393?query=nextarrow"><FONT SIZE="-1" FACE="arial,helvetica">Next</FONT><IMG ALT="Next" WIDTH="9" HEIGHT="8" HSPACE="4" BORDER="0" SRC="/icons/v2_toc_arrownext.gif"></A></TD>
          		</TR>
				</TABLE>
				
          		</DIV>
      			
      		

      </TD>
    </TR>
</TABLE>
</CENTER>
<P>





<div align="center"><b><FONT SIZE="+2" face="Arial, Helvetica, sans-serif">Case 23-2003 &#151; A 79-Year-Old Woman with Gastric Lymphoma and Erosive Mucosal and Cutaneous Lesions</FONT></B><BR></div>


	
	<CENTER><FONT SIZE="+1"><I>
	
	
			A. Razzaque Ahmed, M.D., Mathew M. Avram, M.D., J.D., and Lyn M. Duncan, M.D.
		
	</I></FONT></CENTER>







<P>

 



 
		                    



 
	 

<table border="0" cellpadding="0" cellspacing="0" width="200" ALIGN="RIGHT">
<tr>
<td width="20">&nbsp;</td>
<TD BGCOLOR="336699">

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1">

	<TR VALIGN="top">
		<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
			<img src="/icons/v3_this_article.gif" alt="This Article" width="73" height="8" BORDER="0"><BR>
			<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr><tr>
		<td> 
                <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
		<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
		
		
		
		

		
		 

		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b>
			
			
			
				
						
						<A class="contentboxLinks" HREF="/cgi/reprint/349/4/382.pdf">PDF</A></b></font></td></tr>
		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=pda_mms&doi=10.1056%2FNEJMcpc030016">PDA Full Text</A></b></font></td></tr>
		
		
		

		

		

		 
		
		



	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>









	<tr> 
	<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_tools_service.gif" alt="Tools and Services" width="103" height="9" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr>
	<tr> 
	<td> 
	<table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	
		
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/folders?action=addtofolder&wherefrom=JOURNALS&wrapped_id=nejm;349/4/382">Add to Personal Archive</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/citmgr?gca=nejm;349/4/382">Add to Citation Manager</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/mailafriend?url=http://content.nejm.org/cgi/content/short/349/4/382&title=Case+23-2003+-+A+79-Year-Old+Woman+with+Gastric+Lymphoma+and+Erosive+Mucosal+and+Cutaneous+Lesions"><b>Notify a Friend</b></a></b></font></td></tr>

	
        <tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=nejm;349/4/382&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F349%2F4%2F382">E-mail When Cited</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=letters_mms&doi=10.1056%2FNEJMcpc030016">E-mail When Letters Appear</A></b></font></td></tr>
	
	
	
	

	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>



        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_more_information.gif" alt="More Information" width="116" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        

	

	

	

	

	

	

	

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/search?qbe=nejm;349/4/382&journalcode=nejm&minscore=5000">Find Similar Articles</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/external_ref?access_num=12878746&link_type=PUBMED" onClick="ISIwin('ISI')" TARGET="ISI">PubMed Citation</A></b></font></td></tr>

<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
</table>
</td>
</tr>

        
        
</table>
</table>	 <!-- end of outer content box1 -->
</TABLE>	 <!-- end of outer content box2 -->










 





	
	
	
	
	
	
	
	
	
		


<!-- <CENTER><H2><FONT FACE="arial, helvetica">
Case 23-2003
</FONT></H2> </CENTER> -->
<!-- <H3>
A 79-Year-Old Woman with Gastric Lymphoma and Erosive Mucosal and Cutaneous Lesions
</H3> -->


<!--<CENTER><I>
</NOBR><NOBR>A. Razzaque Ahmed, M.D.</NOBR>, 
<NOBR>Mathew M. Avram, M.D., J.D.</NOBR> and 
<NOBR>Lyn M. Duncan, M.D.</NOBR>
</I></CENTER><P>
-->


<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Presentation of Case</STRONG></FONT><P>

A 79-year-old woman with a gastric B-cell lymphoma of the mucosa-associated<SUP> </SUP>lymphoid tissue (MALT) type was admitted to the hospital because<SUP> </SUP>of erosive mucosal and cutaneous lesions.<SUP> </SUP><P>

The patient had been well until 14 months before admission,<SUP> </SUP>when she began to have cramping abdominal pain and to pass black,<SUP> </SUP>tarry stools. Endoscopic ultrasonographic examination of the<SUP> </SUP>upper gastrointestinal tract to the second part of the duodenum,<SUP> </SUP>performed 13 months before admission, revealed a large, submucosal,<SUP> </SUP>noncircumferential mass, 6 by 3 cm, involving the cardia and<SUP> </SUP>gastroesophageal junction, without associated bleeding or ulceration;<SUP> </SUP>the mass was well defined and did not appear to be locally invasive.<SUP> </SUP>Examination of a specimen obtained by fine-needle aspiration<SUP> </SUP>showed morphologic and immunophenotypic evidence of an extranodal,<SUP> </SUP>marginal-zone, B-cell lymphoma of the MALT type.<SUP> </SUP><P>

A complete blood count and the results of routine blood-chemistry<SUP> </SUP>tests were normal. A test for antibodies against <I>Helicobacter<SUP> </SUP>pylori</I> was negative. Thoracic and abdominopelvic computed tomographic<SUP> </SUP>(CT) scanning revealed an enhancing, solid mass that was 6.8<SUP> </SUP>by 4.0 cm and had a lobulated contour. The mass protruded into<SUP> </SUP>the lumen of the stomach but did not obstruct it. There were<SUP> </SUP>multiple enlarged lymph nodes in the gastrohepatic ligament<SUP> </SUP>and porta hepatis; the largest was 2.1 cm in diameter. There<SUP> </SUP>were three subpleural nodules, each 2 to 3 mm in diameter, in<SUP> </SUP>the right lung, but there was no hilar or mediastinal lymphadenopathy.<SUP> </SUP>Whole-body scanning with gallium-67 and positron-emission tomographic<SUP> </SUP>scanning revealed no evidence of disease outside the abdomen.<SUP> </SUP><P>

Beginning 10 months before admission, the patient received radiation<SUP> </SUP>therapy to the upper abdomen in 20 fractions, each 180 cGy,<SUP> </SUP>over a period of 6 weeks; she tolerated therapy with the help<SUP> </SUP>of prochlorperazine and ondansetron. She then decided against<SUP> </SUP>further treatment, and she also became heavily involved in the<SUP> </SUP>home care of her husband, who had oxygen-dependent chronic obstructive<SUP> </SUP>pulmonary disease.<SUP> </SUP><P>

Two months before admission, painful oral ulcerations that involved<SUP> </SUP>much of the oropharynx developed. Fluconazole was administered,<SUP> </SUP>without improvement. One month before admission, the patient<SUP> </SUP>was admitted to another hospital because of asthma. Methylprednisolone<SUP> </SUP>and levofloxacin were given for six days, and the bronchospasm<SUP> </SUP>improved. Three weeks before admission, a rash appeared over<SUP> </SUP>the patient's entire body; it consisted of round, erythematous<SUP> </SUP>lesions, each 5 to 10 mm in diameter, that enlarged and coalesced<SUP> </SUP>into ulcerations with scabs that adhered to her clothing. She<SUP> </SUP>again was admitted to the other hospital, where acyclovir given<SUP> </SUP>intravenously for 10 days had no effect. Her eyes became inflamed,<SUP> </SUP>and a culture specimen yielded a growth of methicillin-resistant<SUP> </SUP><I>Staphylococcus aureus;</I> topical erythromycin was administered.<SUP> </SUP>She was admitted to this hospital.<SUP> </SUP><P>

The patient had retired from an office position. She had a long<SUP> </SUP>history of cigarette smoking and consumed one alcoholic drink<SUP> </SUP>daily. She had not recently lost weight or had nausea, vomiting,<SUP> </SUP>or peripheral edema. She had undergone an appendectomy at the<SUP> </SUP>age of 14 years, a cholecystectomy at the age of 49, and a simple<SUP> </SUP>right-sided mastectomy for ductal carcinoma in situ 2 years<SUP> </SUP>before admission. She had a history of asthma that had begun<SUP> </SUP>at the age of 40 and had had atrial fibrillation with congestive<SUP> </SUP>heart failure six years before admission. Her medications comprised<SUP> </SUP>nebulized salmeterol and fluticasone, amiodarone, tamoxifen,<SUP> </SUP>omeprazole, and vitamins. A brother had died of a brain tumor<SUP> </SUP>at the age of 27 years, and an elderly aunt had been treated<SUP> </SUP>for lymphoma and pancreatic cancer.<SUP> </SUP><P>

The temperature was 37.9&#176;C, the pulse was 108 beats per<SUP> </SUP>minute, and the respiratory rate was 24 breaths per minute.<SUP> </SUP>The blood pressure was 110/50 mm Hg.<SUP> </SUP><P>

Over the patient's trunk, arms, and legs were multiple round,<SUP> </SUP>erythematous plaques, some of which were tender; they had coalesced<SUP> </SUP>into larger plaques that did not blanch completely on pressure<SUP> </SUP>(<A HREF="#F1">Figure 1</A>). The lesions had ulcerations in the center, with<SUP> </SUP>mucoid secretions that adhered to the patient's clothing; some<SUP> </SUP>of the lesions contained scabs, and others bled slightly. Her<SUP> </SUP>eyelids were edematous, and her conjunctivae were injected,<SUP> </SUP>with greenish secretions. Buccal erosions were also present.<SUP> </SUP>The site of the right-sided mastectomy was unremarkable, and<SUP> </SUP>the left breast was normal. The lungs and heart were normal.<SUP> </SUP>The liver edge descended 2 to 3 cm; the spleen was not felt,<SUP> </SUP>and no mass or ascites was detected. There was edema (+) of<SUP> </SUP>both legs, with intact pulses. Rectal examination revealed no<SUP> </SUP>abnormalities; a stool specimen was negative for occult blood.<SUP> </SUP><P>

<A NAME="F1"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/349/4/382/F1"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=58 HEIGHT=128 SRC="/content/vol349/issue4/images/small/14f1.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (44K):<BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/F1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/F1"
    onClick="startTarget('F1', 350, 640); this.href='/cgi/content-nw/full/349/4/382/F1'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 1.</B> Photographs of the Skin and Mucosal Lesions on Admission.<P>

On the back (Panel A), there are numerous erosions, 0.5 to 3.0 cm in diameter, with pink, moist bases and punctate areas of hemorrhage. In addition, there are numerous poorly defined pink macules. The inset shows a close-up view of a large erosion that has coalesced with adjoining erosions. Peripheral collarettes of scale suggest that these erosions formed from bullae that had ruptured. Large, coalescent erosions with moist, erythematous bases are present on the chest, with numerous sites of pinpoint bleeding. There are numerous erosions on the lips (Panel B), with hemorrhagic crusting, pinpoint bleeding, and an adherent white-yellow exudate. There are also erosions on the tongue, most prominently on the lateral surfaces, as well as erosive gingivitis. The inferior palpebral conjunctiva of the left eye (Panel C) has erosions and is edematous and erythematous. There is whitish-yellow discharge emerging from the left medial canthus.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


The levels of conjugated and total bilirubin, alkaline phosphatase,<SUP> </SUP>and lactic dehydrogenase were normal. Other laboratory values<SUP> </SUP>are shown in <A HREF="#T1">Table 1</A> and <A HREF="#T2">Table 2</A>. CT scanning of the thorax<SUP> </SUP>and abdomen, performed after the intravenous and oral administration<SUP> </SUP>of contrast material, showed no change in the subpleural nodules,<SUP> </SUP>which were suspected to be granulomas, and no hilar lymphadenopathy.<SUP> </SUP>The gastric mass, at 3.2 cm in diameter, was smaller than it<SUP> </SUP>had been before radiation therapy, and the gastrohepatic lymphadenopathy<SUP> </SUP>was markedly improved; the largest node in the gastrohepatic<SUP> </SUP>ligament measured 1.3 by 0.9 cm.<SUP> </SUP><P>

<A NAME="T1"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/T1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/T1"
    onClick="startTarget('T1', 593, 585); this.href='/cgi/content-nw/full/349/4/382/T1'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 1.</B> Hematologic Laboratory Data on Admission.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<A NAME="T2"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/T2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/T2"
    onClick="startTarget('T2', 593, 865); this.href='/cgi/content-nw/full/349/4/382/T2'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 2.</B> Blood Chemical Values on Admission.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


A diagnostic procedure was performed.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Differential Diagnosis</STRONG></FONT><P>

<I>Dr. A. Razzaque Ahmed:</I> May we see the radiographic studies and<SUP> </SUP>the clinical photographs of the skin lesions?<SUP> </SUP><P>

<I>Dr. Jason L. Kelly</I> (Radiology): A contrast-enhanced image from<SUP> </SUP>the CT scan of the abdomen obtained 13 months before the current<SUP> </SUP>admission revealed a large, lobulated mass in the lesser curvature<SUP> </SUP>of the stomach and several enlarged lymph nodes in the perigastric<SUP> </SUP>region and the gastrohepatic ligament. The CT scan obtained<SUP> </SUP>on the current admission showed a reduction in the size of the<SUP> </SUP>mass and the sizes of the lymph nodes.<SUP> </SUP><P>

<I>Dr. Mathew M. Avram:</I> A photograph of the patient's back (<A HREF="#F1">Figure 1A</A>)<SUP> </SUP>shows numerous erosions, 0.5 to 3.0 cm in diameter, with<SUP> </SUP>pink, moist bases, numerous sites of pinpoint bleeding, and<SUP> </SUP>peripheral collarettes of scale, suggesting that the erosions<SUP> </SUP>had developed from bullae that had ruptured. In addition, there<SUP> </SUP>are multiple poorly defined pink macules. On the chest there<SUP> </SUP>was a large, confluent erosion similar to those on the back.<SUP> </SUP>There are numerous erosions on the lips and tongue (<A HREF="#F1">Figure 1B</A>),<SUP> </SUP>as well as erosive gingivitis. There are erosions and erythema<SUP> </SUP>of the conjunctivae, with purulent secretions (<A HREF="#F1">Figure 1C</A>).<SUP> </SUP><P>

<I>Dr. Ahmed:</I> The clinical manifestations of this case require<SUP> </SUP>us to focus on four categories of diseases: infections, cutaneous<SUP> </SUP>involvement by lymphoma, mucocutaneous diseases not associated<SUP> </SUP>with malignant tumors, and mucocutaneous diseases associated<SUP> </SUP>with malignant tumors. The mucocutaneous disease in this case<SUP> </SUP>probably does not have an infectious cause, because there was<SUP> </SUP>no response to antifungal or antiviral therapies and because<SUP> </SUP>there was no systemic involvement. It is also unlikely to be<SUP> </SUP>a sign of cutaneous involvement by lymphoma. Cutaneous lymphomas<SUP> </SUP>have morphologic features unlike those in this case and are<SUP> </SUP>not associated with such extensive and rapidly developing mucosal<SUP> </SUP>disease. They form multiple, large, infiltrated plaques, papules<SUP> </SUP>or nodules, which may be either normal or violaceous in color<SUP> </SUP>or purpuric.<SUP> </SUP><P>

Of the third category, mucocutaneous diseases not related to<SUP> </SUP>a neoplasm, the most relevant disorders are erythema multiforme,<SUP> </SUP>the Stevens&#150;Johnson syndrome, and toxic epidermal necrolysis.<A HREF="#R1"><SUP>1</SUP></A><SUP>,</SUP><A HREF="#R2"><SUP>2</SUP></A><SUP> </SUP>Erythema multiforme is an acute or recurrent, usually self-limited<SUP> </SUP>disorder that results in cutaneous plaques and target-shaped<SUP> </SUP>lesions that are usually acral in distribution. Oral lesions<SUP> </SUP>may occur. The disease is most often due to herpes simplex virus<SUP> </SUP>infection. In the current case, the widespread involvement of<SUP> </SUP>the skin, the progressive nature of the process, and the absence<SUP> </SUP>of a response to antiviral therapy make erythema multiforme<SUP> </SUP>an unlikely diagnosis. The Stevens&#150;Johnson syndrome and<SUP> </SUP>toxic epidermal necrolysis are drug-related and cause extensive,<SUP> </SUP>necrotizing cutaneous and mucosal lesions. In this case, the<SUP> </SUP>polymorphic appearance of the skin involvement, the lack of<SUP> </SUP>distinctive necrosis and sloughing, and the absence of a history<SUP> </SUP>of drug administration decrease but do not eliminate the likelihood<SUP> </SUP>of toxic epidermal necrolysis.<SUP> </SUP><P>

The fourth category, mucocutaneous paraneoplastic syndromes<SUP> </SUP>associated with hematologic cancers, includes neutrophilic dermatosis<SUP> </SUP>(e.g., Sweet's syndrome and pyoderma gangrenosum), reactive<SUP> </SUP>erythemas (e.g., erythroderma and exfoliative dermatitis), vascular<SUP> </SUP>dermatosis (e.g., vasculitis and erythromelalgia), papulosquamous<SUP> </SUP>disorders (e.g., acquired ichthyosis), and vesiculobullous diseases.<A HREF="#R3"><SUP>3</SUP></A><SUP> </SUP>Except for vesiculobullous diseases, these possibilities are<SUP> </SUP>unlikely diagnoses in this case, given the patient's history,<SUP> </SUP>her clinical presentation, and the appearance of her skin lesions.<SUP> </SUP>The focus of the differential diagnosis in this case is therefore<SUP> </SUP>on vesiculobullous diseases. Three entities need to be considered:<SUP> </SUP>pemphigus, pemphigoid, and paraneoplastic pemphigus (<A HREF="#T3">Table 3</A>).<SUP> </SUP><P>

<A NAME="T3"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/T3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/T3"
    onClick="startTarget('T3', 950, 639); this.href='/cgi/content-nw/full/349/4/382/T3'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 3.</B> Mucocutaneous Paraneoplastic Vesiculobullous Disorders Associated with Hematologic Cancers.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<STRONG>Pemphigus</STRONG><P>

Pemphigus is a group of blistering diseases characterized by<SUP> </SUP>acantholysis (loss of cell adhesion) and by in vivo deposition<SUP> </SUP>of autoantibodies against desmoglein.<A HREF="#R4"><SUP>4</SUP></A> In pemphigus foliaceus,<SUP> </SUP>the acantholysis occurs in the upper epidermis and the autoantibody<SUP> </SUP>is targeted to desmoglein 1. Pemphigus foliaceus involves only<SUP> </SUP>the skin. In pemphigus vulgaris, the acantholysis occurs in<SUP> </SUP>the deeper layers of the epidermis, and autoantibodies target<SUP> </SUP>desmogleins 1 and 3. Pemphigus vulgaris affects both the skin<SUP> </SUP>and the mucosa, although some patients have only mucosal disease.<SUP> </SUP>In both of these diseases, examination of perilesional skin<SUP> </SUP>by direct immunofluorescence shows, in almost all patients,<SUP> </SUP>deposition of IgG on the surfaces of keratinocytes, and indirect<SUP> </SUP>immunofluorescence detects the autoantibody in the serum.<SUP> </SUP><P>

Both pemphigus foliaceus and pemphigus vulgaris have been reported<SUP> </SUP>in association with cancer,<A HREF="#R5"><SUP>5</SUP></A> but the association is more common<SUP> </SUP>with pemphigus vulgaris. The most common malignant tumors in<SUP> </SUP>patients with pemphigus are Kaposi's sarcoma and lymphoid neoplasms,<SUP> </SUP>including Hodgkin's and non-Hodgkin's lymphomas and chronic<SUP> </SUP>lymphocytic leukemia.<SUP> </SUP><P>

In the case under discussion, the presence of marked mucosal<SUP> </SUP>disease rules out the diagnosis of pemphigus foliaceus. The<SUP> </SUP>polymorphic nature and rapid and progressive onset of the cutaneous<SUP> </SUP>involvement would be unusual in pemphigus vulgaris, but direct<SUP> </SUP>and indirect immunofluorescence analysis would be necessary<SUP> </SUP>to rule it out.<SUP> </SUP><P>

<STRONG>Pemphigoid</STRONG><P>

Pemphigoid<A HREF="#R4"><SUP>4</SUP></A> is a group of diseases that typically affect the<SUP> </SUP>elderly and that are characterized by the presence of autoantibodies<SUP> </SUP>to a component of the basement-membrane zone. Histologic examination<SUP> </SUP>reveals subepidermal blisters and a mixed inflammatory-cell<SUP> </SUP>infiltrate in the dermis. Bullous pemphigoid is characterized<SUP> </SUP>by large, tense bullae in an acral distribution; mucosal involvement<SUP> </SUP>is rare. Mucous-membrane pemphigoid, also referred to as cicatricial<SUP> </SUP>pemphigoid, invariably involves one or multiple mucous membranes,<SUP> </SUP>involves the skin only occasionally, and is distinguished from<SUP> </SUP>other blistering diseases by the fact that as the blisters heal<SUP> </SUP>there is considerable scarring.<A HREF="#R6"><SUP>6</SUP></A><SUP> </SUP><P>

In bullous pemphigoid and mucous-membrane pemphigoid, IgG and<SUP> </SUP>C3 are deposited in the basement-membrane zone and can be visualized<SUP> </SUP>by direct immunofluorescence. Patients with bullous pemphigoid<SUP> </SUP>have circulating antibodies to a 230-kD desmoplakin protein<SUP> </SUP>(bullous pemphigoid antigen 1) and a 180-kD hemidesmosomal protein<SUP> </SUP>(bullous pemphigoid antigen 2). Serum from patients with cicatricial<SUP> </SUP>pemphigoid has antibodies to bullous pemphigoid antigen 2, human<SUP> </SUP><IMG SRC="/math/beta.gif" ALT="{beta}" BORDER="0"><SUB>4</SUB> integrin, and possibly other, unidentified basement-membrane<SUP> </SUP>zone and adhesion molecules.<SUP> </SUP><P>

In the case under discussion, the presence of mucosal disease<SUP> </SUP>makes bullous pemphigoid an unlikely diagnosis. The extensive<SUP> </SUP>and persistent polymorphic cutaneous involvement makes mucous-membrane<SUP> </SUP>pemphigoid unlikely, but it would be prudent to rule it out<SUP> </SUP>by histologic and immunopathological examination of the skin<SUP> </SUP>and serum.<SUP> </SUP><P>

<STRONG>Paraneoplastic Pemphigus</STRONG><P>

Anhalt et al.<A HREF="#R7"><SUP>7</SUP></A> first described paraneoplastic pemphigus as a<SUP> </SUP>distinct entity in 1990 and provided criteria for the diagnosis.<SUP> </SUP>Camisa and Helm<A HREF="#R8"><SUP>8</SUP></A> later revised these criteria in order to simplify<SUP> </SUP>and facilitate the diagnosis (<A HREF="#T4">Table 4</A>). These guidelines propose<SUP> </SUP>that all three major criteria and at least two minor criteria<SUP> </SUP>should be met before the disease is diagnosed. The most characteristic<SUP> </SUP>clinical feature of paraneoplastic pemphigus is intractable,<SUP> </SUP>painful stomatitis affecting the entire oral cavity and the<SUP> </SUP>lips.<A HREF="#R7"><SUP>7</SUP></A><SUP>,</SUP><A HREF="#R9"><SUP>9</SUP></A> It is the most consistent feature of this disease and<SUP> </SUP>usually is the first symptom, and it is often resistant to therapy.<SUP> </SUP>Conjunctival involvement is present in approximately two thirds<SUP> </SUP>of patients and may be severe, causing pseudomembranous conjunctivitis,<SUP> </SUP>symblepharon, and marked visual impairment. Anogenital involvement,<SUP> </SUP>particularly of the penis, is common. Esophageal erosions can<SUP> </SUP>be present.<SUP> </SUP><P>

<A NAME="T4"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/T4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/T4"
    onClick="startTarget('T4', 733, 580); this.href='/cgi/content-nw/full/349/4/382/T4'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 4.</B> Revised Criteria for the Diagnosis of Paraneoplastic Pemphigus, Proposed by Camisa and Helm.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


Skin involvement is reported in almost all patients, with polymorphic<SUP> </SUP>lesions affecting more than half the body surface. The lesions<SUP> </SUP>may include flaccid or tense bullae, with or without erosions;<SUP> </SUP>lichenoid lesions like those seen in erythema multiforme; and<SUP> </SUP>confluent erythema. The cutaneous lesions in an individual patient<SUP> </SUP>may have different morphologic features at a single point in<SUP> </SUP>time or at various intervals over the course of the disease.<SUP> </SUP>The trunk and the proximal portions of the arms and legs are<SUP> </SUP>the most frequently involved areas. Palmar, plantar, or paronychial<SUP> </SUP>involvement is often observed.<SUP> </SUP><P>

Although respiratory infections can complicate paraneoplastic<SUP> </SUP>pemphigus, direct involvement of the tracheobronchial tree can<SUP> </SUP>also occur, causing obstructive respiratory failure and death.<A HREF="#R10"><SUP>10</SUP></A><SUP> </SUP>Bronchoscopic examination may reveal inflammation, vesicles,<SUP> </SUP>or erosions.<A HREF="#R11"><SUP>11</SUP></A> Paraneoplastic pemphigus may be associated with<SUP> </SUP>brochiolitis obliterans with organizing pneumonia, particularly<SUP> </SUP>in young patients with Castleman's disease.<A HREF="#R12"><SUP>12</SUP></A><SUP> </SUP><P>

The histologic features of paraneoplastic pemphigus include<SUP> </SUP>both intraepidermal acantholysis and suprabasilar clefting.<A HREF="#R13"><SUP>13</SUP></A><SUP> </SUP>Direct-immunofluorescence studies of skin-biopsy specimens typically<SUP> </SUP>show deposition of IgG, with or without complement, both on<SUP> </SUP>the surfaces of keratinocytes and on the basement-membrane zone.<A HREF="#R14"><SUP>14</SUP></A><SUP> </SUP>Indirect immunofluorescence studies performed with the use of<SUP> </SUP>stratified squamous epithelium (such as monkey esophagus or<SUP> </SUP>bovine tongue) as a substrate can detect antibodies in serum<SUP> </SUP>from patients with pemphigus vulgaris, pemphigus foliaceus,<SUP> </SUP>or paraneoplastic pemphigus. In contrast, urinary-bladder epithelium<SUP> </SUP>contains desmoplakins but not desmogleins and is therefore a<SUP> </SUP>suitable substrate for distinguishing paraneoplastic pemphigus<SUP> </SUP>from these other diseases. Immunoprecipitation or immunofluorescence<SUP> </SUP>studies can detect autoantibodies to plectin, desmoplakins I<SUP> </SUP>and II, envoplakin, periplakin, bullous pemphigoid antigen 2,<SUP> </SUP>desmogleins 1 and 3, and an unknown, 170-kD protein in serum<SUP> </SUP>from patients with paraneoplastic pemphigus.<A HREF="#R14"><SUP>14</SUP></A><SUP>,</SUP><A HREF="#R15"><SUP>15</SUP></A><SUP> </SUP><P>

Seventy to 75 percent of patients with paraneoplastic pemphigus<SUP> </SUP>are known to have cancer at the time of the diagnosis, whereas<SUP> </SUP>in other patients cancer is discovered subsequently.<A HREF="#R7"><SUP>7</SUP></A><SUP>,</SUP><A HREF="#R9"><SUP>9</SUP></A> By far<SUP> </SUP>the most common associations are with B-cell lymphomas, leukemias,<SUP> </SUP>and Castleman's disease (<A HREF="#T5">Table 5</A>). Castleman's disease is essentially<SUP> </SUP>the only disorder associated with paraneoplastic pemphigus in<SUP> </SUP>patients younger than 20 years of age.<A HREF="#R9"><SUP>9</SUP></A> Common tumors such as<SUP> </SUP>adenocarcinoma of the breast, bowel, or lung or basal-cell or<SUP> </SUP>squamous-cell carcinoma of the skin have not been frequently<SUP> </SUP>associated with paraneoplastic pemphigus.<A HREF="#R9"><SUP>9</SUP></A><SUP> </SUP><P>

<A NAME="T5"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/T5">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/T5"
    onClick="startTarget('T5', 595, 589); this.href='/cgi/content-nw/full/349/4/382/T5'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T5">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 5.</B> Approximate Frequency of Diseases Associated with Paraneoplastic Pemphigus.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


In patients with a resectable lesion such as Castleman's disease<SUP> </SUP>or thymoma, complete resection of the tumor is generally accompanied<SUP> </SUP>by considerable improvement and, in some cases, remission.<A HREF="#R9"><SUP>9</SUP></A><SUP> </SUP>Unfortunately, in patients with malignant neoplasms, treatment<SUP> </SUP>of the cancer is often not associated with improvement of the<SUP> </SUP>paraneoplastic pemphigus, which is often very resistant to therapy;<SUP> </SUP>mortality has approached 90 percent in many studies. Death has<SUP> </SUP>been attributed to multiple factors, including respiratory failure,<SUP> </SUP>sepsis, gastrointestinal bleeding, and multiorgan failure.<A HREF="#R9"><SUP>9</SUP></A><SUP> </SUP><P>

My clinical diagnosis in this case is paraneoplastic pemphigus,<SUP> </SUP>but pemphigus vulgaris, cicatricial pemphigoid, and toxic epidermal<SUP> </SUP>necrolysis must be ruled out before the diagnosis can be established<SUP> </SUP>with certainty. A biopsy of the skin with appropriate histopathological<SUP> </SUP>and immunopathological examination would confirm the diagnosis.<SUP> </SUP><P>

<I>Dr. Robert T. McCluskey</I> (Pathology): Dr. Ryan, would you describe<SUP> </SUP>your thoughts about this patient before the diagnostic procedure?<SUP> </SUP><P>

<I>Dr. David P. Ryan</I> (Medical Oncology): The patient's gastric<SUP> </SUP>MALT lymphoma did not respond to therapy with antibiotics and<SUP> </SUP>responded only partly to radiation therapy, with persistent<SUP> </SUP>MALT lymphoma observed on subsequent examination of biopsy specimens<SUP> </SUP>of the stomach. Nonetheless, she felt well and opted for observation<SUP> </SUP>rather than surgical resection of the mass. She did well until<SUP> </SUP>the oral and cutaneous lesions developed, at which time her<SUP> </SUP>disease was restaged and CT scanning showed persistence of the<SUP> </SUP>gastric mass. We were concerned about paraneoplastic pemphigus<SUP> </SUP>and also about the possibility of lymphomatous involvement of<SUP> </SUP>the skin and mucous membranes. We consulted Dr. Avram, of the<SUP> </SUP>Department of Dermatology, and he performed a skin biopsy.<SUP> </SUP><P>

<I>Dr. McCluskey:</I> Dr. Avram, would you discuss your thoughts about<SUP> </SUP>this case before the biopsy results were obtained?<SUP> </SUP><P>

<I>Dr. Avram:</I> Our differential diagnosis was very similar to that<SUP> </SUP>proposed by Dr. Ahmed. We believed that the patient had either<SUP> </SUP>pemphigus vulgaris or paraneoplastic pemphigus. Although paraneoplastic<SUP> </SUP>pemphigus is the less common of the two disorders, the severity<SUP> </SUP>and persistence of the mucosal and cutaneous involvement, together<SUP> </SUP>with the presence of persistent B-cell lymphoma, led us to favor<SUP> </SUP>that diagnosis.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Clinical Diagnosis</STRONG></FONT><P>

Paraneoplastic pemphigus.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Dr. A. Razzaque Ahmed's Diagnosis</STRONG></FONT><P>

Paraneoplastic pemphigus.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Pathological Discussion</STRONG></FONT><P>

<I>Dr. Lyn M. Duncan:</I> The diagnosis of gastric marginal-zone B-cell<SUP> </SUP>lymphoma of the MALT type was established by a combination of<SUP> </SUP>morphologic and flow-cytometric analysis of endoscopically obtained<SUP> </SUP>fine-needle aspirates. The specimens predominantly contained<SUP> </SUP>small lymphoid cells with slightly irregular nuclei and abundant<SUP> </SUP>cytoplasm (known as marginal-zone B cells) and plasma cells;<SUP> </SUP>a few large lymphoid cells were also present. Flow-cytometric<SUP> </SUP>analysis revealed a population of lambda light-chain&#150;restricted<SUP> </SUP>B cells expressing CD20 and CD19 but not CD5, CD10, CD43, or<SUP> </SUP>CD23. These results, together with the clinical and morphologic<SUP> </SUP>findings, were diagnostic of extranodal marginal-zone B-cell<SUP> </SUP>lymphoma of the MALT type, also known as MALT lymphoma.<SUP> </SUP><P>

The diagnostic procedures were punch biopsies of the skin. Biopsy<SUP> </SUP>specimens of skin from the left arm and skin from the left thigh<SUP> </SUP>were sent for routine histologic processing and direct immunofluorescence<SUP> </SUP>staining, respectively. The skin-biopsy specimen from the left<SUP> </SUP>arm revealed a blistering process characterized by detachment<SUP> </SUP>of the epidermis from the dermis (<A HREF="#F2">Figure 2A</A>). The dermis was<SUP> </SUP>denuded of epithelium except for a focus along one margin, where<SUP> </SUP>a few keratinocytes remained attached to the surface. The detached<SUP> </SUP>epidermal blister roof had an intact epidermal surface with<SUP> </SUP>acantholysis of keratinocytes in the lower layers of the stratum<SUP> </SUP>spinosum (<A HREF="#F2">Figure 2B</A>). These findings are typical of paraneoplastic<SUP> </SUP>pemphigus, in which there is both detachment of cells from one<SUP> </SUP>another (acantholysis and suprabasal clefting) and focal detachment<SUP> </SUP>from the basement membrane (subepidermal clefting). These findings<SUP> </SUP>contrast with those in cases of pemphigus, in which there is<SUP> </SUP>only suprabasal acantholysis and clefting, and pemphigoid, in<SUP> </SUP>which the clefting is only subepidermal (<A HREF="#T3">Table 3</A> and <A HREF="#F3">Figure 3</A>).<SUP> </SUP>The loss of adherence both between the basal-layer keratinocytes<SUP> </SUP>and the dermis and between the individual keratinocytes of the<SUP> </SUP>lower epidermis is consistent with a process that affects proteins<SUP> </SUP>that are integral to desmosomes, which mediate the cohesion<SUP> </SUP>of the cells to one another, and to hemidesmosomes, which in<SUP> </SUP>turn mediate the attachment of keratinocytes to the basement-membrane<SUP> </SUP>zone. Other features that distinguish paraneoplastic pemphigus<SUP> </SUP>from pemphigus vulgaris include the presence of apoptosis of<SUP> </SUP>keratinocytes and often a more prominent lichenoid inflammatory<SUP> </SUP>infiltrate in the dermis.<SUP> </SUP><P>

<A NAME="F2"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/349/4/382/F2"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=66 HEIGHT=128 SRC="/content/vol349/issue4/images/small/14f2.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (53K):<BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/F2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/F2"
    onClick="startTarget('F2', 377, 640); this.href='/cgi/content-nw/full/349/4/382/F2'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 2.</B> Biopsy Specimens of the Skin.<P>

The dermis is denuded of epithelium, except for a small focus of retained basal keratinocytes (Panel A; hematoxylin and eosin, <FONT FACE="arial,helvetica">x</FONT>250). The detached epidermal blister roof has an intact epidermal surface with acantholysis of keratinocytes in the lower layers of the stratum spinosum (Panel B; hematoxylin and eosin, <FONT FACE="arial,helvetica">x</FONT>500). Direct immunofluorescence staining with the use of skin from the patient's left thigh as a substrate and fluorescein-conjugated antibodies to detect human complement (Panel C) shows deposition of C3 along the epidermal basement-membrane zone (arrows) and in a netlike intercellular pattern between the keratinocytes of the lower epidermis &#151; an appearance characteristic of paraneoplastic pemphigus (immunofluorescence with antibody to human C3, <FONT FACE="arial,helvetica">x</FONT>250).<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<A NAME="F3"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/349/4/382/F3"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=128 HEIGHT=109 SRC="/content/vol349/issue4/images/small/14f3.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (74K):<BR>
<NOBR><A HREF="/cgi/content/full/349/4/382/F3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/349/4/382/F3"
    onClick="startTarget('F3', 590, 575); this.href='/cgi/content-nw/full/349/4/382/F3'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 3.</B> Pathophysiology of Autoimmune Blistering Diseases of the Skin and Mucosae.<P>

Normal epidermis (Panel A) contains desmosomes that mediate attachment between keratinocytes and hemidesmosomes that mediate attachment between keratinocytes and the basement membrane. In pemphigus (Panel B), antibodies to desmosomal proteins are associated with the detachment of keratinocytes from one another (i.e., acantholysis), producing a suprabasal cleft and a netlike pattern of keratinocyte cell-surface staining on direct immunofluorescence. In pemphigoid (Panel C), antibodies to hemidesmosomal proteins are associated with the detachment of keratinocytes from the basement membrane, resulting in a subepidermal cleft and a linear basement-membrane&#150;zone pattern of staining on direct immunofluorescence. In paraneoplastic pemphigus (Panel C), antibodies to desmosomal and hemidesmosomal proteins are associated with both acantholysis and suprabasal and subepidermal clefting and produce a combined pattern of staining on immunofluorescence.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


Direct immunofluorescence staining with use of the patient's<SUP> </SUP>skin as a substrate and fluorescein-conjugated antibodies directed<SUP> </SUP>against human immunoglobulins and complement revealed IgG and<SUP> </SUP>C3 both along the epidermal basement zone and between the keratinocytes<SUP> </SUP>of the lower epidermis, in an intercellular, netlike pattern<SUP> </SUP>(<A HREF="#F2">Figure 2C</A>). Indirect immunofluorescence studies of dilutions<SUP> </SUP>of the patient's serum applied to a monkey-esophagus substrate<SUP> </SUP>revealed circulating antibodies that bound to the intercellular<SUP> </SUP>regions of the epithelium at a titer of 1:80.<SUP> </SUP><P>

The proteins targeted by autoantibodies in pemphigus are localized<SUP> </SUP>to the desmosomes; in pemphigoid, they are localized to the<SUP> </SUP>hemidesmosomes; and in paraneoplastic pemphigus, they are localized<SUP> </SUP>to both (<A HREF="#F3">Figure 3</A>). The binding of antibody to these proteins<SUP> </SUP>is associated with acantholysis, detachment of cells from the<SUP> </SUP>basement membrane, or both these processes. Desmogleins 1 and<SUP> </SUP>3, which are targeted in pemphigus, are found only in desmosomes.<A HREF="#R16"><SUP>16</SUP></A><SUP> </SUP>In contrast, the two antigens targeted in pemphigoid are present<SUP> </SUP>only in hemidesmosomes: bullous pemphigoid antigen 1 is an intracellular<SUP> </SUP>desmoplakin component of the hemidesmosome, and bullous pemphigoid<SUP> </SUP>antigen 2 is a unique transmembrane protein that interacts with<SUP> </SUP>hemidesmosomes and the basement membrane.<A HREF="#R17"><SUP>17</SUP></A> Antibodies to both<SUP> </SUP>desmogleins 1 and 3 and bullous pemphigoid antigen 2 are present<SUP> </SUP>in paraneoplastic pemphigus. Other plakins targeted by autoantibodies<SUP> </SUP>in paraneoplastic pemphigus are components of both desmosomes<SUP> </SUP>and hemidesmosomes (<A HREF="#T3">Table 3</A>).<A HREF="#R18"><SUP>18</SUP></A> The antibodies and other immunoreactants<SUP> </SUP>are visualized in situ by staining for human IgG and C3. In<SUP> </SUP>paraneoplastic pemphigus, IgG and C3 are deposited in an intercellular<SUP> </SUP>netlike pattern corresponding to desmosomes (in a manner similar<SUP> </SUP>to that in pemphigus) and also along the epidermal basement-membrane<SUP> </SUP>zone, corresponding to hemidesmosomes (in a manner similar to<SUP> </SUP>that in pemphigoid). The presence of staining in both of these<SUP> </SUP>distributions is characteristic of paraneoplastic pemphigus<SUP> </SUP>and distinguishes it from both pemphigus and pemphigoid.<SUP> </SUP><P>

Since the combination of clinical, pathological, and immunopathological<SUP> </SUP>findings in this case is characteristic of paraneoplastic pemphigus<SUP> </SUP>and since recent studies have not shown a correlation between<SUP> </SUP>the serum autoantibody profile and the clinical phenotype,<A HREF="#R19"><SUP>19</SUP></A><SUP> </SUP>immunoprecipitation studies were not performed in this patient.<SUP> </SUP><P>

No cases specifically classified as MALT lymphoma have been<SUP> </SUP>reported in association with paraneoplastic pemphigus. In most<SUP> </SUP>reports, however, the lymphomas are not well characterized,<SUP> </SUP>and it is possible that some of them may be MALT lymphomas.<SUP> </SUP><P>

<I>Dr. McCluskey:</I> Dr. Ryan, would you describe this patient's follow-up?<SUP> </SUP><P>

<I>Dr. Ryan:</I> The patient was initially treated with corticosteroids<SUP> </SUP>and mycophenolate mofetil, with only modest improvement in the<SUP> </SUP>lesions on the skin and virtually no improvement in the mucosal<SUP> </SUP>lesions. We decided to add weekly treatment with anti-CD20 monoclonal<SUP> </SUP>antibody (rituximab) to attempt to control the B-cell lymphoma,<SUP> </SUP>since there are reports of patients with paraneoplastic pemphigus<SUP> </SUP>and B-cell lymphoma who had improvement with this treatment.<A HREF="#R20"><SUP>20</SUP></A><SUP>,</SUP><A HREF="#R21"><SUP>21</SUP></A><SUP> </SUP>After two months of therapy, she had tremendous improvement<SUP> </SUP>in her skin lesions and moderate improvement in her oral lesions.<SUP> </SUP>Unfortunately, five months after presentation, she died suddenly<SUP> </SUP>while in a rehabilitation facility. An autopsy was not performed.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Anatomical Diagnosis</STRONG></FONT><P>

Paraneoplastic pemphigus associated with gastric marginal-zone<SUP> </SUP>B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>


<FONT SIZE=-1>Dr. Duncan reports having received grant support from Becton<SUP> </SUP>Dickinson.<SUP> </SUP><P>

</FONT>
<FONT SIZE=-1></FONT>
<BR><FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Source Information</STRONG></FONT><P><FONT SIZE=-1>
From the Department of Oral Medicine, New England Baptist Hospital and Harvard School of Dental Medicine (A.R.A.); the Department of Dermatology (M.M.A.) and the Department of Pathology, Dermatopathology Unit (L.M.D.), Massachusetts General Hospital; and the Departments of Dermatology (A.R.A., M.M.A.) and Pathology (L.M.D.), Harvard Medical School &#151; all in Boston.
</FONT><P>


<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>References</STRONG></FONT><P>

<OL COMPACT>
<A NAME="R1"><!-- null --></A>
<LI VALUE=1>  Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993;129:92-96.<!-- HIGHWIRE ID="349:4:382:1" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=archderm&resid=129/1/92" >[Abstract]</A><!-- /HIGHWIRE --><A NAME="R2"><!-- null --></A>
<LI VALUE=2>  Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995;131:539-543.<!-- HIGHWIRE ID="349:4:382:2" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=archderm&resid=131/5/539" >[Abstract]</A><!-- /HIGHWIRE --><A NAME="R3"><!-- null --></A>
<LI VALUE=3>  Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 1995;99:207-216.<!-- HIGHWIRE ID="349:4:382:3" --><A HREF="/cgi/external_ref?access_num=10.1016/S0002-9343(99)80141-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=A1995RN31900014&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=7625426&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R4"><!-- null --></A>
<LI VALUE=4>  Bickle KM, Roark TR, Hsu S. Autoimmune bullous dermatoses: a review. Am Fam Physician 2002;65:1861-1870.<!-- HIGHWIRE ID="349:4:382:4" --><A HREF="/cgi/external_ref?access_num=000175567900015&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=12018809&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R5"><!-- null --></A>
<LI VALUE=5>  Younus J, Ahmed AR. The relation of pemphigus to neoplasia. J Am Acad Dermatol 1990;23:498-502.<!-- HIGHWIRE ID="349:4:382:5" --><A HREF="/cgi/external_ref?access_num=A1990DX71200018&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=2212152&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R6"><!-- null --></A>
<LI VALUE=6>  Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000;43:571-591.<!-- HIGHWIRE ID="349:4:382:6" --><A HREF="/cgi/external_ref?access_num=10.1067/mjd.2000.107248&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000089671800001&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11004612&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R7"><!-- null --></A>
<LI VALUE=7>  Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-1735.<!-- HIGHWIRE ID="349:4:382:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=nejm&resid=323/25/1729" >[Abstract]</A><!-- /HIGHWIRE --><A NAME="R8"><!-- null --></A>
<LI VALUE=8>  Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993;129:883-886.<!-- HIGHWIRE ID="349:4:382:8" --><A HREF="/cgi/external_ref?access_num=10.1001/archderm.129.7.883&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=A1993LM09100011&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=8323311&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R9"><!-- null --></A>
<LI VALUE=9>  Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997;12:77-96.<!-- HIGHWIRE ID="349:4:382:9" --><A HREF="/cgi/external_ref?access_num=8973736&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R10"><!-- null --></A>
<LI VALUE=10>  Kimyai-Asadi A, Jih MH. Paraneoplastic pemphigus. Int J Dermatol 2001;40:367-372.<!-- HIGHWIRE ID="349:4:382:10" --><A HREF="/cgi/external_ref?access_num=10.1046/j.1365-4362.2001.01169.x&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000171127300001&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11589740&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R11"><!-- null --></A>
<LI VALUE=11>  Osmanski JP II, Fraire AE, Schaefer OP. Necrotizing tracheobronchitis with progressive airflow obstruction associated with paraneoplastic pemphigus. Chest 1997;112:1704-1707.<!-- HIGHWIRE ID="349:4:382:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=chest&resid=112/6/1704" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R12"><!-- null --></A>
<LI VALUE=12>  Mimouni D, Anhalt GJ, Lazarova Z, et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002;147:725-732.<!-- HIGHWIRE ID="349:4:382:12" --><A HREF="/cgi/external_ref?access_num=10.1046/j.1365-2133.2002.04992.x&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000178377600014&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=12366419&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R13"><!-- null --></A>
<LI VALUE=13>  Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pemphigus variants. J Am Acad Dermatol 1999;40:649-671.<!-- HIGHWIRE ID="349:4:382:13" --><A HREF="/cgi/external_ref?access_num=000080029700001&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=10321591&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R14"><!-- null --></A>
<LI VALUE=14>  Hashimoto T. Immunopathology of paraneoplastic pemphigus. Clin Dermatol 2001;19:675-682.<!-- HIGHWIRE ID="349:4:382:14" --><A HREF="/cgi/external_ref?access_num=10.1016/S0738-081X(00)00192-9&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000172273000003&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11705675&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R15"><!-- null --></A>
<LI VALUE=15>  Hashimoto T, Amagai M, Watanabe K, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995;104:829-834.<!-- HIGHWIRE ID="349:4:382:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jidonline&resid=104/5/829" >[Abstract]</A><!-- /HIGHWIRE --><A NAME="R16"><!-- null --></A>
<LI VALUE=16>  Garrod DR, Merritt AJ, Nie Z. Desmosomal cadherins. Curr Opin Cell Biol 2002;14:537-545.<!-- HIGHWIRE ID="349:4:382:16" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(02)00366-6&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000177837900004&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=12231347&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R17"><!-- null --></A>
<LI VALUE=17>  Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet 1999;354:667-672.<!-- HIGHWIRE ID="349:4:382:17" --><A HREF="/cgi/external_ref?access_num=10.1016/S0140-6736(99)03007-X&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000082214500046&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=10466686&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R18"><!-- null --></A>
<LI VALUE=18>  Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin. J Invest Dermatol 2001;116:556-563.<!-- HIGHWIRE ID="349:4:382:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jidonline&resid=116/4/556" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R19"><!-- null --></A>
<LI VALUE=19>  Ohyama M, Amagai M, Hashimoto T, Nousari HC, Anhalt GJ, Nishikawa T. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol 2001;44:593-598.<!-- HIGHWIRE ID="349:4:382:19" --><A HREF="/cgi/external_ref?access_num=10.1067/mjd.2001.112222&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000167768000004&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11260531&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R20"><!-- null --></A>
<LI VALUE=20>  Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hugli A. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269-272.<!-- HIGHWIRE ID="349:4:382:20" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=archderm&resid=137/3/269" ><nobr>[Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R21"><!-- null --></A>
<LI VALUE=21>  Heizmann M, Itin P, Wernli M, Borradori L, Bargetzi MJ. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001;66:142-144.<!-- HIGHWIRE ID="349:4:382:21" --><A HREF="/cgi/external_ref?access_num=10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.3.CO;2-S&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000166410600013&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11421295&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --></OL>






		
        
        
	
	
	
	
	






 




<BR CLEAR=ALL>


	
	 
		  
			 
			
			                    



 
	 

<table border="0" cellpadding="0" cellspacing="0" width="200" ALIGN="RIGHT">
<tr>
<td width="20">&nbsp;</td>
<TD BGCOLOR="336699">

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1">

	<TR VALIGN="top">
		<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
			<img src="/icons/v3_this_article.gif" alt="This Article" width="73" height="8" BORDER="0"><BR>
			<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr><tr>
		<td> 
                <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
		<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
		
		
		
		

		
		 

		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b>
			
			
			
				
						
						<A class="contentboxLinks" HREF="/cgi/reprint/349/4/382.pdf">PDF</A></b></font></td></tr>
		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=pda_mms&doi=10.1056%2FNEJMcpc030016">PDA Full Text</A></b></font></td></tr>
		
		
		

		

		

		 
		
		



	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>









	<tr> 
	<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_tools_service.gif" alt="Tools and Services" width="103" height="9" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr>
	<tr> 
	<td> 
	<table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	
		
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/folders?action=addtofolder&wherefrom=JOURNALS&wrapped_id=nejm;349/4/382">Add to Personal Archive</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/citmgr?gca=nejm;349/4/382">Add to Citation Manager</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/mailafriend?url=http://content.nejm.org/cgi/content/short/349/4/382&title=Case+23-2003+-+A+79-Year-Old+Woman+with+Gastric+Lymphoma+and+Erosive+Mucosal+and+Cutaneous+Lesions"><b>Notify a Friend</b></a></b></font></td></tr>

	
        <tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=nejm;349/4/382&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F349%2F4%2F382">E-mail When Cited</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=letters_mms&doi=10.1056%2FNEJMcpc030016">E-mail When Letters Appear</A></b></font></td></tr>
	
	
	
	

	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>



        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_more_information.gif" alt="More Information" width="116" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        

	

	

	

	

	

	

	

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/search?qbe=nejm;349/4/382&journalcode=nejm&minscore=5000">Find Similar Articles</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/external_ref?access_num=12878746&link_type=PUBMED" onClick="ISIwin('ISI')" TARGET="ISI">PubMed Citation</A></b></font></td></tr>

<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
</table>
</td>
</tr>

        
        
</table>
</table>	 <!-- end of outer content box1 -->
</TABLE>	 <!-- end of outer content box2 -->



			
			
					
	









<BR CLEAR=ALL>


	

	<table width="100%" border="0" cellspacing="0" cellpadding="0" align="center">
	<tr> 
	<td align="center"><hr size="1" color="#000000" noshade>
	<p><font face="arial, helvetica, sans-serif">
	<a href="/" class="footerLinks">HOME</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/search.dtl" class="footerLinks">SEARCH</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/current.shtml" class="footerLinks">CURRENT ISSUE</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/contents-by-date.0.shtml" class="footerLinks">PAST ISSUES</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/collections/" class="footerLinks">COLLECTIONS</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/help/" class="footerLinks">HELP</a>
</font></p>
	<p><font face="arial, helvetica, sans-serif">Comments and questions?
	Please <a href="http://www.nejm.org/custserv/feedback.asp">contact us</a>.</font></p>
	<p><font face="Times New Roman">
	<font face="Times New Roman"><b>The New England Journal of Medicine is owned, published, and <a href="http://www.nejm.org/aboutnejm/copyright.asp">copyrighted</a> &copy; 2005 <A HREF ="http://www.massmed.org/">Massachusetts Medical Society</A>.
	All rights reserved.</b></font>
</font></p></td>
	</tr>
	</table>



        <SCRIPT LANGUAGE="JavaScript">
        <!--
        function startTarget(windowname,wid,hei) {
        
        var dotpos = windowname.indexOf(".");
        if (dotpos > -1)
        {
        var tempwn = windowname.substring(0,dotpos) +
                windowname.substring(dotpos + 1, windowname.length);
        windowname = tempwn;
        }
        var sizestring = 'width=' + wid + ',height=' + hei;
        window.open('',windowname,'scrollbars,resizable,menubar,' + sizestring + '\'');
        }
        // -->
        </SCRIPT>

<script language="JavaScript">
<!--
if ( top != self )
{
     top.location.href = unescape(window.location.pathname);
}

function ISIwin(windowname) {
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1) {
		var tempwn = windowname.substring(0,dotpos) +
        windowname.substring(dotpos + 1, windowname.length);
		windowname = tempwn;
	}
	newwin = window.open('', windowname, 'width=700,height=400,left=30,top=30,screenX=30,screenY=30,resizable,scrollbars,toolbar,location,status,menubar');
	setTimeout('newwin.focus();',250);
}

//-->
</script>

</BODY>
</HTML>

